December 25, 2024 - 02:14

In a recent discussion regarding the state of the housing market, experts revealed that new home sales in the U.S. experienced a notable increase of 5.9% month-over-month in November. This rise comes despite the ongoing challenges posed by high mortgage rates, which continue to deter potential homebuyers from entering the market.
Katie Hubbard, Executive Vice President of Capital Markets at Walton Global, shared her insights on the current trends in homebuilder sentiment and the future of home affordability. She emphasized that many clients are still providing incentives, such as mortgage rate buy-downs, to counteract the impact of elevated mortgage rates. Hubbard expressed skepticism about the possibility of mortgage rates dropping to 6% anytime soon, predicting that they may remain above this threshold even until 2026.
She noted that the ideal mortgage rate for improved affordability is around 5.5%, but the current elevated rates are creating significant challenges for both buyers and builders in the housing market. As the landscape continues to evolve, stakeholders will need to navigate these affordability issues carefully.
March 17, 2026 - 05:46
Virginia joins multi-state lawsuit against OneMain FinancialVirginia has officially joined a coalition of a dozen states in filing a lawsuit against OneMain Financial, a major consumer loan company. The legal action, announced by Attorney General Jay Jones,...
March 16, 2026 - 02:28
Barclays Lifts PT on EOG Resources (EOG) to $140 From $133In a recent move underscoring confidence in the energy sector, investment bank Barclays has increased its price target for EOG Resources, Inc. The firm lifted its target to $140 per share, up from...
March 15, 2026 - 05:53
Peak War Panic Predicted to Grip Markets Within WeeksA leading market strategist warns that global financial markets are likely to experience a peak period of war-induced panic within the next one to three weeks. This forecast comes as both the...
March 14, 2026 - 22:13
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price PerformanceThe valuation of Brazilian medical education leader Afya is under scrutiny following a period of mixed performance for its shares. While the stock experienced a modest single-day gain of...